Literature DB >> 1252881

Randomised controlled trial of computer-held medical records in hypertensive patients.

C J Bulpitt, L J Beilin, E C Coles, C T Dollery, B F Johnson, A D Munro-Faure, S C Turner.   

Abstract

A total of 278 hypertensive patients in three clinics were randomly allocated to have their medical records held in a computer system (136) or on standard hospital notes (142). For the computer system the doctor completed a structured input form, and the information on symptoms, physical findings, and diagnoses was more complete than that in the standard notes. This resulted in certain symptoms and risk factors being recognised more often when the computer system was used. The hypertension clinics' routines were not disrupted by the introduction of a computer-held system, and follow-up consultation times were not affected by the type of records kept, although the first consultation took eight minutes longer when computer documents were completed. The patients remained in the trial for one year and clinical management was assessed from blood pressure control, drop-out rates, and the frequency of performing investigations. These estimates of management showed no significant difference between the two groups, but the attempt to tailor the computer system to help management made the system acceptable to the doctors using it. The computer system continues to be used and is providing data for research into hypertension.

Entities:  

Mesh:

Year:  1976        PMID: 1252881      PMCID: PMC1639159          DOI: 10.1136/bmj.1.6011.677

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  3 in total

1.  A symptom questionnaire for hypertensive patients.

Authors:  C J Bulpitt; C T Dollery; S Carne
Journal:  J Chronic Dis       Date:  1974-08

2.  Computer-based hypertension clinic records: a co-operative study.

Authors:  L J Beilin; C J Bulpitt; E C Coles; C T Dollery; B F Johnson; C Mearns; A D Munro-Faure; S C Turner
Journal:  Br Med J       Date:  1974-04-27

3.  Towards the development of electronic data-processing systems for medical records.

Authors:  A E Bennett; W W Holland
Journal:  Lancet       Date:  1965-12-04       Impact factor: 79.321

  3 in total
  8 in total

1.  Cancer mortality and atenolol treatment.

Authors:  A E Fletcher; D G Beevers; C J Bulpitt; E C Coles; C T Dollery; J G Ledingham; A J Palmer; J C Petrie; J Webster
Journal:  BMJ       Date:  1993-03-06

2.  Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics.

Authors:  L J Beilin; C J Bulpitt; E C Coles; C T Dollery; J S Gear; G Harper; B F Johnson; A D Munro-Faure; S C Turner
Journal:  Br Heart J       Date:  1980-01

Review 3.  Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review.

Authors:  Tom Fahey; Knut Schroeder; Shah Ebrahim
Journal:  Br J Gen Pract       Date:  2005-11       Impact factor: 5.386

Review 4.  Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review.

Authors:  Liam G Glynn; Andrew W Murphy; Susan M Smith; Knut Schroeder; Tom Fahey
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

5.  Initial care of hypertensive patients. Influence of different types of clinical records.

Authors:  C T Dollery; L J Beilin; C J Bulpitt; E C Coles; B F Johnson; A D Munro-Faure; S C Turner
Journal:  Br Heart J       Date:  1977-02

6.  A systematic review of the use of computers in the management of hypertension.

Authors:  A A Montgomery; T Fahey
Journal:  J Epidemiol Community Health       Date:  1998-08       Impact factor: 3.710

7.  Computerisation of diabetic clinic records.

Authors:  G B Watkins; T Sutcliffe; D A Pyke; P J Watkins
Journal:  Br Med J       Date:  1980-11-22

8.  No magic bullets: a systematic review of 102 trials of interventions to improve professional practice.

Authors:  A D Oxman; M A Thomson; D A Davis; R B Haynes
Journal:  CMAJ       Date:  1995-11-15       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.